The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2

Recently, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was quickly identified as the causal pathogen leading to the outbreak of SARS-like illness all over the world. As the SARS-CoV-2 infection pandemic proceeds, many efforts are being dedicated to the development of diverse trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sheng-Fan, Chen, Kuan-Hsuan, Wang, Szu-Yu, Yarmishyn, Aliaksandr A., Lai, Wei-Yi, Lin, Yi-Ying, Wang, Mong-Lien, Chou, Shih-Jie, Yang, Yi-Ping, Chang, Yuh-Lih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493775/
https://www.ncbi.nlm.nih.gov/pubmed/32433345
http://dx.doi.org/10.1097/JCMA.0000000000000353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493775/
https://www.ncbi.nlm.nih.gov/pubmed/32433345
http://dx.doi.org/10.1097/JCMA.0000000000000353

Ejemplares similares